These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22913901)

  • 41. Liver disease and diabetes: association, pathophysiology, and management.
    Ahmadieh H; Azar ST
    Diabetes Res Clin Pract; 2014 Apr; 104(1):53-62. PubMed ID: 24485856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes is associated with chronic liver disease and liver cancer in the adult population of Puerto Rico.
    Ortiz AP; Romero C; Disdier O; Santana E; Torres M; Torres EA; Pérez CM
    P R Health Sci J; 2011 Sep; 30(3):132-4. PubMed ID: 21932714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases.
    Chung W; Promrat K; Wands J
    World J Hepatol; 2020 Sep; 12(9):533-557. PubMed ID: 33033564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overlooked muscle cramps in patients with chronic liver disease: in relation to the prevalence of muscle cramps.
    Murata A; Hyogo H; Nonaka M; Sumioka A; Suehiro Y; Furudoi A; Fujimoto Y; Aisaka Y; Komatsu H; Tokumo H
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):375-381. PubMed ID: 30362994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current and Future Burden of Chronic Nonmalignant Liver Disease.
    Udompap P; Kim D; Kim WR
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2031-41. PubMed ID: 26291665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Goals of glycemic control in frail older patients with diabetes.
    Lee SJ; Eng C
    JAMA; 2011 Apr; 305(13):1350-1. PubMed ID: 21467289
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease.
    Kuriyama S; Miwa Y; Fukushima H; Nakamura H; Toda K; Shiraki M; Nagaki M; Yamamoto M; Tomita E; Moriwaki H
    J Clin Biochem Nutr; 2007 Mar; 40(2):116-22. PubMed ID: 18188413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The multifaceted associations of hepatobiliary disease and diabetes.
    Bell DS; Allbright E
    Endocr Pract; 2007; 13(3):300-12. PubMed ID: 17599864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetology and oncology meet in a network model: union is strength.
    Gallo M; Gentile L; Arvat E; Bertetto O; Clemente G
    Acta Diabetol; 2016 Aug; 53(4):515-24. PubMed ID: 26862082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.
    Lee HA; Chang Y; Sung PS; Yoon EL; Lee HW; Yoo JJ; Lee YS; An J; Song DS; Cho YY; Kim SU; Kim YJ
    Clin Mol Hepatol; 2022 Jul; 28(3):425-472. PubMed ID: 35850495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study.
    Asrani SK; Hall L; Hagan M; Sharma S; Yeramaneni S; Trotter J; Talwalkar J; Kanwal F
    Am J Gastroenterol; 2019 Jan; 114(1):98-106. PubMed ID: 30333543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms!
    Nachit M; Leclercq IA
    Clin Sci (Lond); 2019 Feb; 133(3):465-481. PubMed ID: 30755499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases.
    Younossi ZM; Golabi P; Henry L
    J Clin Gastroenterol; 2019; 53(5):331-341. PubMed ID: 30702486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer.
    Chatterjee R; Mitra A
    Int Immunopharmacol; 2015 Feb; 24(2):335-345. PubMed ID: 25560752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Liver diseases].
    Nagoshi S
    Nihon Rinsho; 2014 Apr; 72(4):726-9. PubMed ID: 24796105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The cutting-edge of medicine; the cutting-edge of fatty liver disease and diabetes].
    Kon K; Watanabe S
    Nihon Naika Gakkai Zasshi; 2014 Dec; 103(12):3118-25. PubMed ID: 25812345
    [No Abstract]   [Full Text] [Related]  

  • 57. Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD).
    Hamed AE; Elsahar M; Elwan NM; El-Nakeep S; Naguib M; Soliman HH; Aboubakr AA; AbdelMaqsod A; Sedrak H; Assaad SN; Elwakil R; Esmat G; Salh S; Mostafa T; Mogawer S; Sadek SE; Saber MM; Ezelarab H; Mahmoud AA; Sultan S; El Kassas M; Kamal E; ElSayed NM; Moussa S;
    Arab J Gastroenterol; 2019 Mar; 20(1):61-63. PubMed ID: 30852101
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study.
    Porter IE; Palmer WC; Parker AS; Hodge DO; Diehl NN; Haley WE
    J Clin Exp Hepatol; 2018 Dec; 8(4):375-379. PubMed ID: 30563998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes in long-term care facilities.
    Singhal A; Segal AR; Munshi MN
    Curr Diab Rep; 2014 Mar; 14(3):464. PubMed ID: 24464338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes due to chronic liver disease.
    S Afr Med J; 1968 Apr; 42(15):354. PubMed ID: 5648252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.